Pieris Pharmaceuticals: Q3 Earnings Snapshot
Pieris Pharmaceuticals: Q2 Earnings Snapshot
Pieris Pharmaceuticals: Q1 Earnings Snapshot
Pieris Pharmaceuticals: Q3 Earnings Snapshot
Pieris Pharmaceuticals: Q1 Earnings Snapshot
Pieris Pharmaceuticals: Q3 Earnings Snapshot
BOSTON, MA / ACCESSWIRE / June 2, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...
Catalio Capital Management, LP (“Catalio”), a leading multi-strategy life sciences investment firm, today announced that Chau Khuong, who was most recently a Partner at OrbiMed Advisors, has joined...
BOSTON, MA / ACCESSWIRE / May 18, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...
Company To Host an Investor Conference Call On Wednesday, May 11, 2022 At 8:00 Am EDT BOSTON, MA / ACCESSWIRE / May 11, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology...